KRAS and colorectal carcinoma: Collectively, the series of experiments revealed that the combination of CTX and PD effectively decreased tumor growth by decreasing cell proliferation (Ki67) and increasing cell death (apoptosis) in KRAS-mutant CRC cell lines.